The story of Viagra offers a tangled case study for drug stakeholders. Initially a runaway success, generating billions in profits, the patent lapse has exposed the problems of relying on a single product. While generic versions have drastically eroded share, questions remain about the overall ou
Viagra, Vegas, and Vipers: A copyright Scam?
The copyright market is known for its unpredictable nature. This week, the latest trend seems to be a meme coin dubbed "Viagra, Vegas, and Vipers." This token has exploded in value, fueled by hype about its potential to disrupt the market landscape. Some investors are excited, while others are ca